Review of Cannabis Health Risks: Psychosis Link Strong, Withdrawal Syndrome Real, Gateway Theory Debated | Research

The takeaway

A comprehensive review found strong evidence linking cannabis to psychosis and other mental health conditions, supported the existence of a cannabis withdrawal syndrome, and called for more research on effective prevention and treatment strategies.

Read this if you want a broad overview of the health risks associated with cannabis use, particularly regarding mental health.

Strong support found for a link between cannabis and the development and exacerbation of psychosis

What the researchers found

This review covered multiple dimensions of cannabis health effects and comorbidity. The physiological and neurological effects of cannabis were reviewed alongside prevalence data and the gateway drug hypothesis.

The review found strong support for a link between cannabis and the development and exacerbation of psychosis. Links to anxiety and depression were also supported, though the evidence was less definitive.

Regarding dependence, the review supported the existence of a cannabis withdrawal syndrome with diagnostic criteria. The question of whether cannabis serves as a "gateway" to harder drugs was discussed but not definitively resolved.

The authors called for further research into the neurochemical processes underlying cannabis-mental health relationships, the social factors driving increasing youth cannabis use, and systematic evaluation of prevention and treatment programs through randomized controlled trials.

Why it matters

By addressing the full spectrum of cannabis health risks in a single review, this paper provided a comprehensive resource for clinicians and policymakers. The emphasis on cannabis being potentially more harmful than traditionally perceived, particularly regarding mental health, reflected a shift in research consensus in the mid-2000s.

The numbers in context

Strong evidence for cannabis-psychosis link. Support for cannabis withdrawal syndrome as a diagnosable condition. Cannabis identified as one of the most commonly used illicit drugs globally.

How the study worked

Narrative review examining published literature on cannabis physiological effects, prevalence, gateway hypothesis, dependence criteria, withdrawal syndrome, and comorbidity with psychosis, anxiety, and depression. Also reviewed public health prevention and treatment programs.

What this study cannot tell us

As a narrative review, it did not systematically grade the quality of evidence for each claim. The causal direction of the cannabis-mental health relationship was acknowledged as uncertain. Prevention program evidence was limited.

How to read the evidence

Comprehensive narrative review covering multiple health domains. Provides a useful overview but does not use systematic review methodology.

When this study was published

Published in 2005. Subsequent research has generally strengthened the evidence for the cannabis-psychosis link and has better characterized cannabis withdrawal syndrome.

The bigger picture

This review captured a pivotal moment when the scientific community was reassessing the relative harmfulness of cannabis, particularly regarding mental health effects. The call for randomized controlled trials of prevention and treatment interventions reflected the growing recognition that cannabis-related problems deserved the same research attention as alcohol and other drugs.

Questions still open

What are the specific neurochemical mechanisms by which cannabis contributes to psychosis? Why is cannabis use increasing among young people, and what prevention strategies are effective?

Common questions

Is cannabis really less harmful than other drugs?

This review challenged that assumption, noting that while cannabis effects have traditionally been seen as less harmful than alcohol or cocaine, current research supports real health risks including psychosis, anxiety, depression, and dependence with withdrawal symptoms.

Is there a cannabis withdrawal syndrome?

Yes. This review supported the existence of a diagnosable cannabis withdrawal syndrome, including specific diagnostic criteria. While generally less severe than withdrawal from alcohol or opioids, it is a real clinical phenomenon that can complicate efforts to quit.

Read the original research

Comorbidity: cannabis and complexity.

Journal of psychiatric practice, 11(3), 161-76

View on PubMed ↗

Citation

Raphael, Beverley; Wooding, Sally; Stevens, Garry; Connor, Jason. (2005). Comorbidity: cannabis and complexity.. Journal of psychiatric practice, 11(3), 161-76.